Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04212169 · ClinicalTrials.gov registry record · Phase 2

Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis

A Phase 2 study of Atopic Dermatitis, sponsored by AstraZeneca.

Completed
Registry status
Phase 2
Development phase
148
Enrollment target
20
Study locations

NCT04212169 is a Phase 2 study of Atopic Dermatitis that has completed, run by AstraZeneca. The registered enrollment target is 148 participants, below the 608-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (76% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04212169, a Phase 2 study of Atopic Dermatitis, has completed, sponsored by AstraZeneca.

COMPLETED
Registry status
Phase 2
Development phase
148 participants
Enrollment target
20
Study locations

Study Summary

This is a research study to determine the efficacy and safety of investigational drug MEDI3506 for the treatment of adult subjects with Atopic Dermatitis.

Conditions Studied

Atopic Dermatitis

Interventions

  • DRUG Placebo
  • DRUG MEDI3506

Study Locations (20)

Other

  • Research Site - Box Hill
  • Research Site - Carlton
  • Research Site - East Melbourne
  • Research Site - Fremantle
  • Research Site - Berlin
  • Research Site - Dresden
  • Research Site - Hamburg

Florida

  • Research Site - Jacksonville
  • Research Site - Miami
  • Research Site - Orlando

Texas

  • Research Site - San Antonio
  • Research Site - San Antonio

Alabama

  • Research Site - Birmingham

California

  • Research Site - Santa Monica

Louisiana

  • Research Site - Baton Rouge

North Carolina

  • Research Site - Charlotte

Oklahoma

  • Research Site - Tulsa

Trial Details

FieldValue
Enrollment Target 148 participants
Start Date 2019-12-09
Est. Completion 2022-09-20
Phase Phase 2

Sponsor

AstraZeneca

1,285 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04212169

The ClinicalTrials.gov registry entry for NCT04212169 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (76% lower). The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atopic Dermatitis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04212169 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Other, Florida, Texas.

Frequently Asked Questions

What is clinical trial NCT04212169 about?

NCT04212169 is a clinical study titled "Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis". This is a research study to determine the efficacy and safety of investigational drug MEDI3506 for the treatment of adult subjects with Atopic Dermatitis.

What is the current status of trial NCT04212169?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 148 participants. The study started on 2019-12-09. Estimated completion is 2022-09-20.

What conditions does trial NCT04212169 study?

This clinical trial studies the following conditions: Atopic Dermatitis.

What interventions are being tested in trial NCT04212169?

The interventions under investigation include: Placebo (DRUG), MEDI3506 (DRUG).

Who is sponsoring clinical trial NCT04212169?

This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04212169 being conducted?

This trial has 20 study locations across Alabama, California, Florida, Louisiana, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atopic Dermatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atopic Dermatitis

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.